Philadelphia Duragesic Pain Patch Lawyers
Contact us for a free legal consultation about your Duragesic Pain Patch Lawsuit
- Duragesic Patches
- Duragesic Patch Lawsuit: Pain Gel Fentanyl Leaked
- Duragesic Patch Recall-February 2008: Need a Patch Recall Lawyer?
- Duragesic and Fentanyl: FDA Resources & the Black Box Warning
- Past Pain Patch Recalls and Warnings
- Pain Patch Manufacturers
- Fentanyl: Chronic Pain Reliever, Opioid, Pain Patch
- Fentora: Death Climb after One Year on the Market
- Actiq: Death by Lollipop Narcotic Pain Killer
- Web Resources: Unsafe Drug Litigation, Duragesic Patch Recall, Fentanyl, Fentora, Actiq
- About Duragesic Patch Recall Lawyers: Retain Anapol Schwartz, NJ and PA Law Firm
- Are Duragesic Pain Patches Safe?
- Johnson & Johnson’s Medical Recall Saga has a New Chapter
- Should You Contact a Lawyer about the Duragesic Pain Patch Recall?
- Steps to Take with Duragesic Pain Patch Problems
- What to Expect with your Duragesic Pain Patch Trial
- FDA Seeks Safer Solutions for Fentanyl Pain Patch Patients
- News Blog
Actiq: Death by Lollipop Narcotic Pain Killer
Actiq lollipop has been associated with the deaths of at least 127 people.
Actiq is a powerful narcotic painkiller in the form of a lollipop that is manufactured by Cephalon, Inc. which also manufactures Fentora. Actiq is delivered to the bloodstream by a lollipop-like lozenge; when placed against the inner cheek. Pain is relieved in minutes unlike Duragesic patch which takes 8 to 12 hours initially.
The active ingredient, fentanyl citrate, is a highly addictive narcotic which is approximately 80 times more potent than morphine. Actiq lollipop Lozenge is an opioid analgesic narcotic Actiq relieves pain by dulling the pain center in the brain.
In 1998, the FDA approved the Actiq lollipop for treatment of cancer patients who experienced extreme pain. However, these days Actiq is prescribed off-label to thousands of people for non-cancer related pain. During the first six months of 2006 approximately 99 percent of the 187,076 Actiq prescriptions filled in the United States were not prescribed for cancer patients.
The Actiq lollipop has been associated with the deaths of at least 127 people. There have been another 91 incidents of severe side effects reported to the FDA. Side effects have ranged from dehydration to respiratory problems along with issues associated with the addictive nature of narcotics. One-third of the deaths have been linked to addiction, misuse, or overdose. Two deaths involved children who had access to and unfortunately mistook the Actiq lollipop for candy.
Severe Actiq lollipop side effects include rash, hives, difficulty breathing, tightness in the chest, swelling of the mouth, face, lips, or tongue; excessive dizziness, excessive drowsiness, fainting, fatigue, hallucinations, muscle rigidity, seizures, shock (changes in skin color), slow heartbeat, slowed breathing, trouble breathing, and weakness.
Other common Actiq side effects are accidental injury, anxiety, confusion, constipation, difficulty walking, drowsiness, dizziness, dry mouth, headache, indigestion, itching, nausea, and vomiting. Call your doctor if these don’t disappear.
- Has your loved one been recklessly prescribed Actiq lollipop?
- Has your loved one died from the pain killer Actiq lollipop?
- Has a loved one been erroneously prescribed Actiq and is now dependent or addicted?
If you answered yes to one or more of the above questions then you may be eligible to file an Actiq lawsuit. Please contact the law firm, Anapol Schwartz, who can answer your questions and help you determine an Actiq legal plan of action. There is no obligation to proceed and your conversation is private and complimentary.
